Passage Bio appoints Simona King as CFO, effective August 23, 2021

Passage BIO, Inc.

Simona King, age 49, named CFO; most recently CFO of Tmunity Therapeutics (Sep 2020–Jun 2021).
Annual base salary of $425,000, cash bonus up to 40% of base, and option for 360,000 shares.
Options vest 1/4 after one year, then monthly over 3 years; severance includes 9–12 months salary.
Bruce Goldsmith (CEO) serves as interim Principal Financial Officer until King's start date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Simona King

Chief Financial Officer

PASG · Passage BIO, Inc.

Effective: 2021-08-23
Filed: July 21, 2021, 7:59 PM ET

appointed Simona King, age 49, as Chief Financial Officer, effective on or about August 23, 2021

Appointed (interim)

Bruce Goldsmith

Principal Financial Officer

PASG · Passage BIO, Inc.

Effective: 2021-07-21
Filed: July 21, 2021, 7:59 PM ET

The Board appointed Bruce Goldsmith, Ph.D., a member of the Board and the Company’s President and Chief Executive Officer, as the Company’s Principal Financial Officer, effective immediately until the Commencement Date

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Simona King was appointed as Chief Financial Officer at Passage BIO, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

appointed Simona King, age 49, as Chief Financial Officer, effective on or about August 23, 2021

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Bruce Goldsmith was appointed as Principal Financial Officer at Passage BIO, Inc..

Action: appointed
Role: Principal Financial Officer

Exact text from the filing

The Board appointed Bruce Goldsmith, Ph.D., a member of the Board and the Company’s President and Chief Executive Officer, as the Company’s Principal Financial Officer, effective immediately until the Commencement Date

View on SEC.gov

Passage BIO, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-21-009027

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.